PMID- 19755790 OWN - NLM STAT- MEDLINE DCOM- 20100402 LR - 20220408 IS - 1880-3873 (Electronic) IS - 1340-3478 (Linking) VI - 16 IP - 6 DP - 2009 TI - CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. PG - 707-13 AB - AIM: Up-regulation of soluble CD40 ligand (sCD40L) and of monocyte chemoattractant protein-1 (MCP-1) has been found in diabetes and in patients with acute cerebral ischemia. We asked whether (i) the two molecules are similarly upregulated among non-lacunar and lacunar diabetic strokes and (ii) sCD40L and/or MCP-1 predict the risk of cardiovascular events in this setting. METHODS: Ninety patients with type 2 diabetes mellitus presenting with an acute ischemic stroke (compared with 45 control subjects) were evaluated on admission and up to 36 months (median 24 months) after the event. RESULTS: Diabetic patients with acute stroke had higher plasma CD40L and MCP-1 than controls (p<0.0001), with no significant differences among lacunar and non-lacunar strokes. On multiple regression analysis, only higher sCD40L quartiles and older age were associated with higher MCP-1 quartiles. Forty-eight percent of patients experienced vascular events. Cox regression analysis showed that only the presence of higher sCD40L values independently predicted the recurrence of vascular events. CONCLUSION: Up-regulation of inflammatory molecules, such as CD40L and MCP-1, is involved in the advanced stage of atherosclerotic cerebro-vascular disease and is associated with increased risk of recurrence of cardiovascular events. FAU - Davi, Giovanni AU - Davi G AD - Department of Medicine and Aging, "G. d'Annunzio" University School of Medicine, Chieti, Italy. gdavi@unich.it FAU - Tuttolomondo, Antonino AU - Tuttolomondo A FAU - Santilli, Francesca AU - Santilli F FAU - Basili, Stefania AU - Basili S FAU - Ferrante, Elisabetta AU - Ferrante E FAU - Di Raimondo, Domenico AU - Di Raimondo D FAU - Pinto, Antonio AU - Pinto A FAU - Licata, Giuseppe AU - Licata G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090916 PL - Japan TA - J Atheroscler Thromb JT - Journal of atherosclerosis and thrombosis JID - 9506298 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 147205-72-9 (CD40 Ligand) SB - IM MH - Aged MH - CD40 Ligand/*biosynthesis MH - Chemokine CCL2/*biosynthesis MH - Cohort Studies MH - Diabetes Complications/*blood MH - Diabetes Mellitus/*blood MH - Female MH - *Gene Expression Regulation MH - Humans MH - Male MH - Middle Aged MH - Regression Analysis MH - Risk MH - Stroke/*blood/*complications MH - Treatment Outcome EDAT- 2009/09/17 06:00 MHDA- 2010/04/03 06:00 CRDT- 2009/09/17 06:00 PHST- 2009/09/17 06:00 [entrez] PHST- 2009/09/17 06:00 [pubmed] PHST- 2010/04/03 06:00 [medline] AID - JST.JSTAGE/jat/1537 [pii] AID - 10.5551/jat.1537 [doi] PST - ppublish SO - J Atheroscler Thromb. 2009;16(6):707-13. doi: 10.5551/jat.1537. Epub 2009 Sep 16.